MacroGenics, Inc. (MGNX): Price and Financial Metrics

MacroGenics, Inc. (MGNX): $16.10

0.58 (-3.48%)

POWR Rating

Component Grades








Add MGNX to Watchlist
Sign Up

Industry: Biotech




#85 of 363

in industry

MGNX Price/Volume Stats

Current price $16.10 52-week high $21.88
Prev. close $16.68 52-week low $4.29
Day low $16.00 Volume 953,000
Day high $16.83 Avg. volume 1,470,234
50-day MA $17.02 Dividend yield N/A
200-day MA $9.44 Market Cap 1.01B

MGNX Stock Price Chart Interactive Chart >

MacroGenics, Inc. (MGNX) Company Bio

Macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company was founded in 2000 and is based in Rockville, Maryland.

MGNX Latest News Stream

Event/Time News Detail
Loading, please wait...

MGNX Latest Social Stream

Loading social stream, please wait...

View Full MGNX Social Stream

Latest MGNX News From Around the Web

Below are the latest news stories about MACROGENICS INC that investors may wish to consider to help them evaluate MGNX as an investment opportunity.

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar

With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks.

Josh Enomoto on InvestorPlace | December 17, 2023

Shareholders in MacroGenics (NASDAQ:MGNX) are in the red if they invested three years ago

It is a pleasure to report that the MacroGenics, Inc. ( NASDAQ:MGNX ) is up 74% in the last quarter. But that doesn't...

Yahoo | December 12, 2023

Q3 2023 MacroGenics Inc Earnings Call

Q3 2023 MacroGenics Inc Earnings Call

Yahoo | November 7, 2023

MacroGenics, Inc. (NASDAQ:MGNX) Q3 2023 Earnings Call Transcript

MacroGenics, Inc. (NASDAQ:MGNX) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good afternoon. We will begin the MacroGenics 2023 Third Quarter Corporate Progress and Financial Results Conference Call in just a moment. [Operator Instructions] At this point, I will turn the call over to Jim Karrels, Senior Vice President and Chief Financial Officer of […]

Yahoo | November 7, 2023

MacroGenics (MGNX) Q3 2023 Earnings Call Transcript

At this point, I will turn the call over to Jim Karrels, senior vice president and chief financial officer of MacroGenics. Good afternoon and welcome to MacroGenics conference call to discuss our third quarter 2023 financial and operational results.

Yahoo | November 7, 2023

Read More 'MGNX' Stories Here

MGNX Price Returns

1-mo 3.34%
3-mo 34.17%
6-mo 232.64%
1-year 135.72%
3-year -49.48%
5-year -0.68%
YTD 67.36%
2023 43.37%
2022 -58.19%
2021 -29.79%
2020 110.11%
2019 -14.33%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!